
Opinion|Videos|July 9, 2024
Typical Payer Coverage Criteria for Multiple Sclerosis Therapies
Heidi Crayton, MD, discusses the typical coverage criteria requirements she encounters from payers for currently-approved therapies for multiple sclerosis.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What typical coverage criteria requirements are you seeing from payers with currently-approved therapies for multiple sclerosis (MS)?
- Do you see benefit of ICD-10 coding by different MS phenotypes vs. having only one code?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Pirtobrutinib Outperforms Bendamustine-Rituximab in Frontline CLL/SLL
4
In CLL, New Therapies Offer Potential for Personalized Approaches
5










































